Health ❯Healthcare

Medications

Weight Loss Weight Loss Drugs GLP-1 Drugs Side Effects Diabetes Weight Management Diabetes Medications Weight Loss Medications Weight-loss Drugs GLP-1 Agonists

FDA Approves IL-23 Inhibitor Tremfya for Moderate-to-Severe Crohn’s Disease

Approval follows GALAXI trials that confirmed Tremfya’s superior rates of gut healing compared with standard treatments

Bristol Myers Squibb and Pfizer to Offer Eliquis at 40% Cash-Price Discount

Long-Term Gabapentin Use Linked to Higher Dementia and Cognitive Impairment Risk

Guidelines Tie Diet and Exercise to GLP-1 Drug Success as India Launches Treatments

Frequent Gabapentin Prescriptions Tied to Increased Dementia and Cognitive Impairment Risk

Liraglutide Pilot Study Halves Chronic Migraine Days, Paves Way for Randomized Trials

Senator Maggie Hassan Launches Probe of GSK’s Pediatric Asthma Inhaler Switch

Semaglutide Demonstrates Dual Promise in Type 1 Diabetes and Dementia Prevention

Liraglutide Cuts Chronic Migraine Days by More Than Half

Bariatric Surgery Surpasses GLP-1 Drugs in Real-World Weight Loss

NHS to Expand GP Prescriptions of Mounjaro for Weight Loss

Tufts Chemists Unveil Four-Receptor Obesity Drug to Challenge Bariatric Surgery

EMA Confirms Very Rare Vision Loss Risk Linked to Semaglutide

Excessive Ibuprofen Use Can Cause Gut Damage and Ulcers, Doctor Warns

MHRA Recalls Two Batches of Prescription Paracetamol for Potential Contamination

NHS Weight-Loss Jab Prescriptions Near Three Million as Experts Raise Lifelong Use Concerns

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

MHRA Warns Women on Ozempic, Mounjaro and Wegovy to Use Effective Contraception After Pregnancy Reports

Gemma Collins Battles Three-Week Pneumonia with Home IV Treatment

Mounjaro Delivers Rapid Weight Loss as UK Health Officials Warn of Serious Risks